OSDCME
ARTICLECMECOPE

Ocular Surface Diseases, Disorders, and Dysfunctions®: Volume 5, Number 2

Author(s)/Faculty: Masih Ahmed, MD; Zaina Al-Mohtaseb, MD; David B. Granet, MD, MHCM; Edward J. Holland, MD; Paul M. Karpecki, OD, FAAO; Michael Kinori, MD; Nathan M. Radcliffe, MD; Sarah H. Van Tassel, MD
Release Date: 9/1/2019Expiration Date: 9/1/2020
Credit Type: CME / COPENumber of Credits: 1.25
Content Type: MonographProvider:
Early identification and prompt management of patients with ocular surface disease (OSD) can lessen disease severity and achieve earlier resolution. However, OSD continues to be challenging to differentially diagnose and therefore is frequently undertreated. Consequences of delayed identification and treatment of OSD have detrimental effects, but the continued assessment and refinement of diagnostic and management algorithms, along with advances in ocular imaging and therapeutic modalities, have the potential to enhance visual acuity outcomes and quality of life in patients with OSD. In this publication series, Ocular Surface Diseases, Disorders, & Dysfunctions®, Volume 5, expert clinicians will review and evaluate pertinent advances for the diagnosis, treatment, and management of patients with OSD, as well as offer clinical guidance for the optimal management of challenging case presentations.